BUZZ-Regeneron shares surge to nearly two-year highs on better-than-expected quarterly results

Latest Updates

October 30 - ** Pharmaceutical company Regeneron Pharmaceuticals (REGN.O) shares surged by 11.3% to $911.52

** If the upward momentum holds, the stock is on track to reach its highest level in nearly two years

** The company reported third-quarter adjusted earnings per share of $20.07, beating analysts' expectations of $16.24 per share—data compiled by LSEG

** The company reported third-quarter revenue of $5.12 billion, higher than analysts' estimates of $4.54 billion—LSEG

**Including the day's gain, the stock's year-to-date increase is approximately 18%

(To facilitate non-English speakers, Reuters has automatically translated its reports into several other languages. Because automated translation may contain errors or lack necessary context, Reuters does not guarantee the accuracy of automated translation. The automated translation is provided solely for readers' convenience. Reuters accepts no responsibility for any harm or losses arising from the use of automated translation.)